133355198 | PUO | 89665513 | | 8267773 | 6/20/2006 12:00:00 AM | Musculoskeletal pain | | DIS | Admission Date: 1/30/2006 Report Status: 

Discharge Date: 1/29/2006 ****** FINAL DISCHARGE ORDERS ****** HISRICH , TAMMARA 482-85-96-2 

Service: CAR DISCHARGE PATIENT ON: 8/19/06 AT 01:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: MAINER , SHAVONNE D. , M.D. CODE STATUS: Full code DISPOSITION: Home DISCHARGE MEDICATIONS: AGGRENOX ( ASPIRIN + DIPYRIDAMOLE ) 1 CAPSULE PO BID Override Notice: Override added on 2/12/06 by VALERI , CLAIRE , M.D. , PH.D. on order for WARFARIN SODIUM PO ( ref # 584940881 ) POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN Reason for override: ok Number of Doses Required ( approximate ): 10 ENTERIC COATED ASPIRIN ( ASPIRIN ENTERIC COATED ) 81 MG PO DAILY Override Notice: Override added on 2/12/06 by VALERI , CLAIRE , M.D. , PH.D. on order for WARFARIN SODIUM PO ( ref # 584940881 ) POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN Reason for override: ok LIPITOR ( ATORVASTATIN ) 80 MG PO DAILY Override Notice: Override added on 2/12/06 by VALERI , CLAIRE , M.D. , PH.D. on order for WARFARIN SODIUM PO ( ref # 584940881 ) POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp; WARFARIN Reason for override: ok CHOLESTYRAMINE RESIN DRIED SUGAR FREE 4 GM PO BID DOXAZOSIN 4 MG PO DAILY HOLD IF: sbp &lt;100 HYDROCHLOROTHIAZIDE 12.5MG + LOSARTAN 50 MG 1 TAB PO DAILY HOLD IF: sbp &lt;100 Number of Doses Required ( approximate ): 5 ZESTRIL ( LISINOPRIL ) 30 MG PO DAILY HOLD IF: sbp &lt; 100 LANTUS ( INSULIN GLARGINE ) 10 UNITS SC DAILY GLYBURIDE 10 MG PO DAILY ATENOLOL 50 MG PO DAILY DIET: House / Low chol/low sat. 
fat DIET: House / ADA 2100 cals/dy ACTIVITY: Resume regular exercise FOLLOW UP APPOINTMENT( S ): PUO Cardiology Clinic::Dr. 
Virgen Yueh at 1PM on 5/11/06 scheduled , Dr. Gamello within 1 week for follow up , ALLERGY: NKA ADMIT DIAGNOSIS: r/o MI PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) Musculoskeletal pain OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay dm ( diabetes mellitus ) htn ( hypertension ) hyperlipidemia ( hyperlipidemia ) gastric ulcer CAD s/p RCA stent ( coronary artery disease ) CRI ( chronic renal dysfunction ) bph ( benign prostatic hypertrophy ) hearing loss ( hearing impairment ) OPERATIONS AND PROCEDURES: none. 
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) none. 
BRIEF RESUME OF HOSPITAL COURSE: cc: CP ***************************** HPI: 75M w/ hx of DM , HTN , Hchol , recent CVA ( 4/06 ) , Afib , CRI , CAD/MI s/p RCA stenting ( 2002 ) and poor cardiac f/up ( Dr. Tolman ) p/w CP. States feeling ok when awoke this AM. 
Then had fleeting substernal cp ( 30sec ) w/out SOB , N/V/Radiation , not like prior CP. 
Shortly after had another fleeting episode. 
Concerned came to ED where was pain free. 
Given ASA X 1. Enzymes neg X1 , EKG w/ bs line abnormality but unchanged. 
Per outpt cardiologist , preffered admission to KTDUOO team for R/O. 
HOSPITAL COURSE: 1. ) CARDS: Admitted for R/O. 
While presentation not suspicious for current cardiac event , given history of cardiac dz , mulitple risk factors and atypical presentations assoc w/ dm , reasonable to R/O. 
Note , Pt did have recent negative stress test at KAAH , though limited study. 
In house , continued on ASA , BB , STATIN , ACE. 
His lipids were mildly elevated with LDL 80s , though already on Lipitor 80 and cholestyramine. 
HGA1c was pending at time of discharge but should be followed as outpatient to ensure good DM control. 
Of note , Pt had HR to the 40's inhouse , though asymptomatic. 
He was maintained on lopressor while observed and transitioned to his home dose of Atenolol 50qd which has been a stable , asymptomatic dose. 
Given extremely low risk presentation and r/o , pt was discharged following morning for outpatient follow up. 
If a repeat imaging is performed , may reccomend for chemical stress study as prior stress limited. 
Should note that EKG had evidence of significant LVH and repol abnormality corroberated with recent echo. 
Would continue to assess for possible hypertrophic cardiomyopathy along with familial risk assessment as outpatient. 
Patient also w/ hx of Parox Afib , now in sinus and recent stroke. 
His rate was well cotnrolled in house on BB. On admission , INR was 3.2 and warfarin dose reduced to 2mg ( from 4mg ). 
On following day , INR 3.4. 
Pt instructed to hold dose that evening and will follow in coumadin clinic on 2/22/06 .  
ADDITIONAL COMMENTS: 1. ) Continue medications as directed. 
2. ) If fleeting episodes of pain recur , would not worry ( though notify PCP/caridologist if severe , perisistant , or associated w/ shortness of breath , prior heart attack symptoms. 
Can use motrin for occasional pains. 
3. ) Follow up w/ Dr. Virgen Yueh in PUO cardiology clinic as scheduled. 
4. ) Follow up w/ Dr. Gamello with in one week re: follow up on oral infection. 
DISCHARGE CONDITION: Stable TO DO/PLAN: 1. ) Titrate meds as outpatient. 
2. ) Consider outpatient cardiac imaging ( last done 2005 at KAAH , but limited study-- consider chemical stress ) 3. ) Follow up re: Peri-oral lesions with Dr. Gamello . 
4. ) Follow INR at Coumadin Clinic ( Note , Held on D/C and scheduled for check 2/22/06 No dictated summary ENTERED BY: VALERI , CLAIRE , M.D. , PH.D. ( VN94 ) 8/19/06 @ 12:12 PM ****** END OF DISCHARGE ORDERS ******